sibutramine has been researched along with risperidone in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Lee, J; Lee, TS; Teoh, T | 1 |
| Bolat, N; Dogangun, B; Kayaalp, L; Rustamov, I | 1 |
1 review(s) available for sibutramine and risperidone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
4 other study(ies) available for sibutramine and risperidone
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Catatonia and psychosis associated with sibutramine: a case report and pathophysiologic correlation.
Topics: Adult; Antipsychotic Agents; Appetite Depressants; Body Image; Body Weight; Catatonia; Cyclobutanes; Diet, Reducing; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Psychoses, Substance-Induced; Risperidone | 2008 |
Sibutramine-induced psychotic episode in an adolescent.
Topics: Adolescent; Antipsychotic Agents; Cyclobutanes; Humans; Kleine-Levin Syndrome; Male; Obesity; Psychoses, Substance-Induced; Risk Factors; Risperidone | 2008 |